These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10160488)

  • 21. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy.
    Myers ER; Misurski DA; Swamy GK
    Am J Obstet Gynecol; 2011 Jun; 204(6 Suppl 1):S128-40. PubMed ID: 21640230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cost-effectiveness of prophylaxis and treatment of influenza].
    Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
    [No Abstract]   [Full Text] [Related]  

  • 24. Socioeconomics of influenza and influenza vaccination in Europe.
    Nicholson KG
    Pharmacoeconomics; 1996; 9 Suppl 3():75-8. PubMed ID: 10160492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria.
    Gasparini R; Lucioni C; Lai P; Maggioni P; Sticchi L; Durando P; Morelli P; Comino I; Calderisi S; Crovari P
    Vaccine; 2002 Dec; 20 Suppl 5():B50-4. PubMed ID: 12477420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
    Nichol KL
    Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Policy evaluation for the subsidy for influenza vaccination in elderly.
    Ohkusa Y
    Vaccine; 2005 Mar; 23(17-18):2256-60. PubMed ID: 15755606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
    Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
    Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European Union.
    Shields GE; Elvidge J; Davies LM
    BMJ Open; 2017 Jun; 7(6):e014847. PubMed ID: 28601824
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential cost-effectiveness of annual influenza immunization for infants and toddlers: experience from Canada.
    Skowronski DM; Woolcott JC; Tweed SA; Brunham RC; Marra F
    Vaccine; 2006 May; 24(19):4222-32. PubMed ID: 16423432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness of universal influenza vaccination in a pregnant population.
    Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD
    Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.
    Burckel E; Ashraf T; de Sousa Filho JP; Forleo Neto E; Guarino H; Yauti C; Barreto F de B; Champion L
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):563-76. PubMed ID: 10662481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cost effectiveness of influenza vaccination in children under 2 years old and elderly in Colombia].
    Porras-Ramírez A; Alvis-Guzmán N; Rico-Mendoza A; Alvis-Estrada L; Castañeda-Orjuela CA; Velandia-González MP; de la Hoz-Restrepo F
    Rev Salud Publica (Bogota); 2009 Oct; 11(5):689-99. PubMed ID: 20339595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.
    Aballéa S; Chancellor J; Martin M; Wutzler P; Carrat F; Gasparini R; Toniolo-Neto J; Drummond M; Weinstein M
    Value Health; 2007; 10(2):98-116. PubMed ID: 17391419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Influenza vaccination of hospital healthcare staff from the perspective of the employer: a positive balance].
    Hak E; Knol LM; Wilschut JC; Postma MJ
    Ned Tijdschr Geneeskd; 2010; 154():A1188. PubMed ID: 20977784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
    Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N
    Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral agents for influenza: a comparison of cost-effectiveness data.
    Lynd LD; Goeree R; O'Brien BJ
    Pharmacoeconomics; 2005; 23(11):1083-106. PubMed ID: 16277546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influenza vaccine for healthy working adults.
    Nichol KL
    JAMA; 2001 Jan; 285(3):290; author reply 292. PubMed ID: 11176832
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost-effectiveness of childhood influenza vaccination in England and Wales: Results from a dynamic transmission model.
    Pitman RJ; Nagy LD; Sculpher MJ
    Vaccine; 2013 Jan; 31(6):927-42. PubMed ID: 23246550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.